1.Yu Y, Yu Q, Liu S, Wu C, Zhang X.. (2021) Insight into the binding mode of HIF-2 agonists through molecular dynamic simulations and biological validation., 211 [PMID:33189439][10.1016/j.ejmech.2020.112999]
2.Yu Y, Yang F, Yu Q, Liu S, Wu C, Su K, Yang L, Bao X, Li Z, Li X, Zhang X.. (2021) Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia., 64 (23.0):[PMID:34709043][10.1021/acs.jmedchem.1c01479]
3.Song W, Zhuang J, Zhang N, Ren X, Xu W, Guo M, Diao X, Liu C, Jin J, Wu D, Zhang Y.. (2023) SAR study of 1,2-benzisothiazole dioxide compounds that agonize HIF-2 stabilization and EPO production., 77 [PMID:36521398][10.1016/j.bmc.2022.117041]